Opioids / Sweden's Orexo: Helping Tackle the US Opioid Crisis
Swedish firm Orexo AB, despite its relatively small stature, is playing a major role in combating one of the…
EUROPE
Central & Eastern Europe Pharma Market Snapshot
Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of…
Data / Sweden's Quality Registries: A Gold Mine of Real-World Evidence
Thanks to the cooperation of its citizens, Sweden boasts a comprehensive patient registry of electronic health…
AI / France's Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on…
Biosimilars / Beyond Generics: Dr Reddy's Going Global
Indian generics powerhouse Dr. Reddy’s has prioritized biosimilars as a key component of the global…
Cancer / Oncology Care in Hungary: In Need of Reform
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The…
Specialising to Succeed in the Spanish Women’s Health Market
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be…
Spain Pharma Production Snapshot
Spain’s pharma production experienced steady growth between 2011 and 2017 except for a dip in 2014 which it…
Company Profile / Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape,…
In Conversation
Interview: Gianvito Martino – Scientific Director & Director of the Division of Neuroscience, San Raffaele Scientific Institute (SRSI), Italy
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in academic research. Division director Professor Gianvito Martino discusses the institute’s unique operative model, national limitations, and the future of the neuroscience field as an investment opportunity. Prof. Martino, to start off, the Division of Neuroscience at the San Raffaele Scientific Institute (SRSI)…
Pharma Faces
Michael Ramroth
CEO | Biotest AG
Severin Schwan
CEO | Roche
Guido Rasi
Executive Director | European Medicines Agency (EMA)
Latest Reports
Focus on Sweden
The 2019 Nobel Prize in Physiology or Medicine
The 2019 Nobel Prize in Physiology or Medicine was awarded to three scientists…
Sweden’s Orexo: Helping Tackle the US Opioid Crisis
Swedish firm Orexo AB, despite its relatively small stature, is playing a major…
Read more from Sweden >>
Focus on Spain
New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of…
Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European…
Read more from Spain >>
Focus on France
France: AI & The Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the…
French Cell & Gene Therapy: Finding the Funding
France – one of the most influential countries in the development of gene…
Read more from France >>
Focus on Switzerland
Outsourced Manufacturing: A Swiss Specialty
Unknown to some, Switzerland meanwhile remains both influential and relevant in…
Switzerland: Fresh Tactics in the War on Cancer
With cancer now causing one in eight deaths globally and, in Europe, even…
Read more from Switzerland >>
Legal Q&As
Preclinical and Clinical Trial Requirements: Estonia
All legal aspects surrounding preclinical and clinical trials in Estonia. Prepared in association with TGS Baltic,…
Product Liability: Czech Republic
Want to know more about product liability in Czech Republic? Read on! Prepared in association with PRK Partners, a…
Patents & Trademarks: Luxembourg
Patents and trademarks of drugs in Luxembourg – an overview. Prepared in association with Wildgen, a leading…
Medical Use of Cannabis in Portugal: Current Status and Perspectives
Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of…
Women in Pharma: Spain at the Vanguard
Spanish pharma is performing well-above other industries in terms of the percentage of women it employs in…
First Impressions / Swedish Pharma
Though far from the largest pharma market in Europe, Sweden nevertheless holds strategic importance for global…
Ukraine: Outsourcing Public Procurement
Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant…
A Pivot Towards Recruitment Process Outsourcing (RPO) in the Baltics
As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how…
Speeding Up Access to Innovation in Portugal
A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other…